Skip to main content

West Pharmaceutical Services Inc.

corporate_fare Company Profile

West Pharmaceutical Services Inc.

WST·NYSE·Industrial Applications And Services·CIK 0000105770

WEST PHARMACEUTICAL SERVICES INC is a leading global manufacturer specializing in the design and production of technologically advanced, high-quality, integrated containment and delivery systems for injectable drugs and healthcare products. The company's offerings include primary proprietary packaging, containment solutions, reconstitution and transfer systems, and drug delivery systems, alongside contract manufacturing, analytical lab services, and integrated solutions. Its customer base comprises leading biologic, generic, pharmaceutical, diagnostic, and medical device companies worldwide. The company operates through two global business segments: Proprietary Products and Contract-Manufactured Products. The Proprietary Products segment provides elastomers & primary containment, drug delivery devices, integrated systems, and analytical lab services, primarily to biologic, generic, and pharmaceutical drug customers. This segment's packaging products include stoppers and seals for injectable packaging systems, designed to ensure drug compatibility and stability while supporting operational efficiency. It also offers syringe and cartridge components, including custom solutions for injectable drug applications, and administration systems that enhance safe drug delivery through advanced reconstitution, mixing, and transfer technologies. The company also provides films, coatings, washing, vision inspection, and sterilization processes and services to improve product quality and mitigate contamination and compatibility risks. This segment's portfolio also features drug containment solutions such as vials, syringes, plungers, and cartridges, which offer high-quality alternatives to address glass incompatibility and cold storage challenges, reducing breakage risk. Additionally, it offers various self-injection devices for at-home delivery of injectable therapies.

West Pharmaceutical Services Inc. (NYSE:WST) is a publicly traded company in the Industrial Applications And Services sector. Wiseek monitors WST SEC EDGAR filings and licensed market news in real time, scoring each submission for market-moving significance on a 1–10 scale. Items rated 7 or higher generate instant alerts.

Recent high-impact activity:

  • West Pharmaceutical Services Appoints Michel Lagarde as New President and CEO
  • West Pharma Fully Operational After Cyberattack, No Material Financial Impact Expected
  • Material Cyberattack Disrupts West Pharma's Global Operations, Data Exfiltrated
  • West Pharma Discloses Material Global Cybersecurity Attack, Data Exfiltration, and System Encryption
  • West Pharmaceutical Services Reports Robust Q1 Earnings, Strong Growth, and Significant Share Repurchases

Financial Snapshot

Fiscal year ended December 31, 2025
Revenue
$3.07B
Net Income
$493.7M
Diluted EPS
$6.79
Op. Cash Flow
$754.8M
Free Cash Flow
$468.9M
Gross Profit
$1.1B
Operating Income
$584.9M
Cash & Equivalents
$791.3M
Total Debt
$202.8M
Debt / Equity
0.06×
Net Margin
16.1%
Shares Outstanding
72M sh
Source: 10-K · filed 2026-02-17 · accession 0000105770-26-000010
Browse all tickers starting with W →
$328.82
52-week range · as of 2026-06-01 $206.1 – $330.88
Market cap
$23.23B
Volume
465.3K (0.6× avg)
3-mo avg 745.8K
Live data · 2026-06-14 03:52 UTC · Market closed

show_chartPrice Chart

Loading chart...

feed WST - Latest Insights

WST
Jun 01, 2026, 4:32 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $316.75
Real-time Price: $328.82 info
Change: +$12.07 (+4%) info
Market Cap: $23.23B info
WST
May 20, 2026, 4:04 PM EDT
Filing Type: 8-K/A
Importance Score:
8
Price at Filing: $305.50
Real-time Price: $328.82 info
Change: +$23.32 (+8%) info
Market Cap: $23.23B info
WST
May 11, 2026, 5:41 PM EDT
Source: Dow Jones Newswires
Importance Score:
9
Price at Filing: $315.00
Real-time Price: $328.82 info
Change: +$13.82 (+4%) info
Market Cap: $23.23B info
WST
May 11, 2026, 5:06 PM EDT
Filing Type: 8-K
Importance Score:
9
Price at Filing: $315.00
Real-time Price: $328.82 info
Change: +$13.82 (+4%) info
Market Cap: $23.23B info
WST
Apr 23, 2026, 4:12 PM EDT
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $309.70
Real-time Price: $328.82 info
Change: +$19.12 (+6%) info
Market Cap: $23.23B info
WST
Apr 23, 2026, 10:56 AM EDT
Source: Reuters
Importance Score:
9
Price at Filing: $313.01
Real-time Price: $328.82 info
Change: +$15.81 (+5%) info
Market Cap: $23.23B info
WST
Apr 23, 2026, 7:11 AM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $325.01
Real-time Price: $328.82 info
Change: +$3.81 (+1%) info
Market Cap: $23.23B info
WST
Apr 23, 2026, 6:22 AM EDT
Source: dpa-AFX
Importance Score:
8
Price at Filing: $283.99
Real-time Price: $328.82 info
Change: +$44.83 (+16%) info
Market Cap: $23.23B info
WST
Apr 23, 2026, 6:03 AM EDT
Source: Dow Jones Newswires
Importance Score:
7
Price at Filing: $283.99
Real-time Price: $328.82 info
Change: +$44.83 (+16%) info
Market Cap: $23.23B info
WST
Mar 12, 2026, 8:31 AM EDT
Filing Type: DEF 14A
Importance Score:
7
Price at Filing: $238.25
Real-time Price: $328.82 info
Change: +$90.57 (+38%) info
Market Cap: $23.23B info
WST
Mar 09, 2026, 4:33 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $248.06
Real-time Price: $328.82 info
Change: +$80.76 (+33%) info
Market Cap: $23.23B info
WST
Feb 17, 2026, 4:28 PM EST
Filing Type: 10-K
Importance Score:
8
Price at Filing: $243.19
Real-time Price: $328.82 info
Change: +$85.63 (+35%) info
Market Cap: $23.23B info
WST
Feb 12, 2026, 7:21 AM EST
Filing Type: 8-K
Importance Score:
7
Price at Filing: $261.02
Real-time Price: $328.82 info
Change: +$67.80 (+26%) info
Market Cap: $23.23B info